The expression and role of SUZ12 in lung adenocarcinoma by Xingsheng Hu, Chunhong Hu, Ping Zhong

Get full text

The exploration of three different treatment models of osimertinib plus antiangiogenic agents in non‐small cell lung cancer: A real‐world study by Yu Feng, Liling Huang, Haohua Zhu, Le Tang, Xingsheng Hu, Yuankai Shi

Get full text

Efficacy and safety of osimertinib plus anlotinib in advanced non‐small‐cell lung cancer patients after drug resistance by Mingzhao Wang, Jun Zhao, Tong Chen, Xingsheng Hu, Lin Wang, Yuankai Shi, Yutao Liu

Get full text

Preparation of double-layered Co−Ci/NiFeOOH co-catalyst for highly meliorated PEC performance in water splitting by Xingsheng Hu, Yan Li, Xinxin Wei, Lei Wang, Houde She, Jingwei Huang, Qizhao Wang

Get full text

Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis by Yu Feng, Yunxia Tao, Haizhu Chen, Yu Zhou, Le Tang, Chenwei Liu, Xingsheng Hu, Yuankai Shi

Get full text

Proteomic profiling reveals the significance of lipid metabolism in small cell lung cancer recurrence and metastasis by Haohua Zhu, Huiyang Shi, Jingyu Lu, Kai Zhu, Lin Yang, Lei Guo, Le Tang, Yuankai Shi, Xingsheng Hu

Get full text

Efficacy and safety of RET-TKI in advanced RET-rearranged non-small cell lung cancer in China: a real-world retrospective chart review by Siyu Lei, Linyan Tian, Lu Yang, Yaning Yang, Junling Li, Xingsheng Hu, Xuezhi Hao, Haiyan Xu, Yan Wang

Get full text

Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer by Dongna Chen, Lin Li, Mingzhao Wang, Xingsheng Hu, Jun Jiang, Weihua Li, Lin Yang, Meng Fan, Yuankai Shi, Fang Lv, Yutao Liu

Get full text

Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas by Yan Li, Tongji Xie, Shouzheng Wang, Lin Yang, Xuezhi Hao, Yan Wang, Xingsheng Hu, Lin Wang, Junling Li, Jianming Ying, Puyuan Xing

Get full text

Disseminated tumor cells in bone marrow as predictive classifiers for small cell lung cancer patients by Ying Wang, Jingying Nong, Baohua Lu, Yuan Gao, Mingming Hu, Cen Chen, Lina Zhang, Jinjing Tan, Xiaomei Yang, Peter Ping Lin, Xingsheng Hu, Tongmei Zhang

Get full text

Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel–based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoa... by Xingsheng Hu, Chunhong Hu, Xianling Liu, Fang Ma, Junpeng Xie, Ping Zhong, Chenxi Tang, Dan Fan, Yuan Gao, Xiang Feng, Mengge Ding, Dezhi Li, Chaoyuan Liu

Get full text

Prognostic significance and underlying mechanisms of STING in lung adenocarcinoma by Haohua Zhu, Yufeng Cao, Jingyu Lu, Lei Guo, Rongrong Luo, Huiyang Shi, Yu Feng, Yutao Liu, Puyuan Xing, Hongyu Wang, Yuankai Shi, Jie Ma, Xingsheng Hu, Peifang Wei

Get full text

Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2) by Guangjian Yang, Haiyan Xu, Yaning Yang, Shuyang Zhang, Fei Xu, Xuezhi Hao, Junling Li, Puyuan Xing, Xingsheng Hu, Yutao Liu, Lin Wang, Lin Lin, Zhijie Wang, Jianchun Duan, Jie Wang, Yan Wang

Get full text

Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer:... by Xingsheng Hu, Xinge Cui, Ziping Wang, Yunpeng Liu, Ying Luo, Wei Zhong, Hui Zhao, Mengxing Yao, Da Jiang, Mingxia Wang, Minjiang Chen, Xin Zheng, Lieming Ding, Yang Wang, Xiaobin Yuan, Pengxiang Wu, Bei Hu, Xiaohong Han, Yuankai Shi

Get full text

Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non... by Chaoyuan Liu, Wei Zhao, Wei Zhao, Junpeng Xie, Huashan Lin, Xingsheng Hu, Chang Li, Youlan Shang, Yapeng Wang, Yingjia Jiang, Mengge Ding, Muyun Peng, Tian Xu, Ao’ran Hu, Yuda Huang, Yuan Gao, Xianling Liu, Jun Liu, Jun Liu, Jun Liu, Fang Ma

Get full text

Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies by Xingsheng Hu, Shucai Zhang, Zhiyong Ma, Jifeng Feng, Lin Wu, Dongqing Lv, Jianying Zhou, Xiaodong Zhang, Li Liu, Qitao Yu, Wangjun Liao, Yiping Zhang, Xiang Wang, Ying Cheng, Hongrui Niu, Ziping Wang, Dong Wang, Cheng Huang, Chunling Liu, Hui Zhao, Jian Feng, Jingzhang Li, Kejing Ying, Nong Yang, Shukui Qin, Jie Hu, Fei Liu, Yong Jiang, Nan Ge, Yuankai Shi

Get full text